Contraindications
As explained in the Intended use, Touchdose is intended to assist Clinical End Users in exercising their clinical judgement when prescribing medications and verifying medication prescriptions. Touchdose is not intended to replace the independent exercise of clinical judgement by healthcare professionals.
Patients for whom sex at birth cannot be unambiguously recorded as Male or Female — including patients with disorders or differences of sex development (DSD) or intersex variations — are contraindicated. Touchdose uses sex at birth to filter the formulary, to validate weight and height percentiles, to determine ideal body weight, to classify obesity, and to display creatinine reference ranges. Use of Touchdose in these patients may produce unsafe dosing recommendations. Refer to local guidelines or specialist input.
A number of specific contraindications arise as a result of the Device limitations, as set out in the Limitations section. These limitations point to circumstances in which decision support offered by Touchdose should be disregarded entirely or be altered based on appropriate clinical judgement. For example, as outlined in the Limitations, it is crucial to note that Touchdose does not consider patient variables or considerations that have not been communicated with the device and in these scenarios, Touchdose should not be used as the sole reference. See the Limitations for information about what the system is unable to take as inputs or consider when making dosing suggestions.
Always refer to the Patient header at the top of Touchdose to check which parameters are being used to inform the dosing recommendations.
Where Touchdose has written a dose recommendation into the EP System's order form, the clinician must review every field of the order, complete any field that Touchdose was unable to populate, and act on any clinical decision support presented by the EP System before signing. See the Limitations section for more information.